Contact Us | Prescribing Info

What is Keratoconus?
- Importance of Early Detection
What is Cross-Linking?
- iLink^® FDA-Approved Cross-Linking
Insurance information
- Cross-Linking & Insurance Guide
Patient Resources
Find an Expert

Living-KC-blue-transparent-background

What is Keratoconus?
- Importance of Early Detection
What is Cross-Linking?
- iLink^® FDA-Approved Cross-Linking
Insurance information
- Cross-Linking & Insurance Guide
Patient Resources
Find an Expert

Sherri Deihl

A Mother’s Perspective: Sherri

December 7, 2021September 25, 2018 by Sherri Diehl

Categories Blog, Sherri Deihl

Recent Posts

Shanice’s Journey to the 2022 IFAF World Championship With Progressive Keratoconus!
Emily’s Keratoconus Journey, Part 1: Before iLink®
Recently Diagnosed with Progressive Keratoconus? Here’s How to Take Control of Your Eye Health!
Fairfax County Times (Fairfax, VA): Female Pro Football Player Overcomes Rare Eye Disease
Keratoconus Journey: Jack

Stay Connected

Sign up for our newsletter and get notifications sent directly to your inbox.

Email**
Consent*
By checking this box and electing to submit this form with your personal data, you confirm that you are at least 18 years old and that you have read and accept the terms of our Privacy Policy. Glaukos will use the information you provide on this form to provide product updates and other promotional materials. Should you change your mind, you may unsubscribe using the link in the footer of any email you receive from us.
I agree.
4 + 7 =
CAPTCHA
Phone
This field is for validation purposes and should be left unchanged.

Recent Posts

Shanice’s Journey to the 2022 IFAF World Championship With Progressive Keratoconus!

Nov 22, 2022

Shanice, 34, was diagnosed with progressive keratoconus during a routine eye exam. However, she has refused to let the disease stop her from pursuing her love of football. Based on the recommendation from her ophthalmologist, Dr. Joseph Iuorno of Commonwealth Eye Care...

Emily’s Keratoconus Journey, Part 1: Before iLink®

Nov 14, 2022

When Emily was in the eighth grade, she noticed that it was difficult for her to see the whiteboard during class. After visiting an eye doctor, Emily was given glasses and sent on her way. At the time, Emily had no idea that this was only the beginning of a long road...

Recently Diagnosed with Progressive Keratoconus? Here’s How to Take Control of Your Eye Health!

Nov 3, 2022

Sight is one of the five basic senses and keeping up with preventative eye care is just as important as scheduling an annual physical exam or dental cleaning. Often, when people think of health, they neglect to consider eye health, especially if they are not...

Fairfax County Times (Fairfax, VA): Female Pro Football Player Overcomes Rare Eye Disease

Oct 31, 2022

“Even though I’m living with KC, the ability to get the [iLink FDA-approved cross-linking] procedure has motivated me to stay active and to keep playing [football].” – Shanice Cole, age 34 After graduating from college, Shanice Cole wanted to enlist in the military....

Contact Us

Headquarters
201 Jones Road
Waltham, MA 02451

Call us: (844) 528-3376
Send an Email

View our Privacy Policy and Terms of Use

© 2022 Living with Keratoconus. Glaukos^® and iLink^® are registered trademarks of Glaukos Corporation. Photrexa^®, Photrexa^® Viscous, and the KXL^® system are registered trademarks of Avedro, a Glaukos company. All Rights Reserved. Glaukos Corporation.

IMPORTANT SAFETY INFORMATION

APPROVED USES
Photrexa^® Viscous (riboflavin 5’-phosphate in 20% dextran ophthalmic solution) and Photrexa^® (riboflavin 5’-phosphate ophthalmic solution) are used with the KXL^® System in corneal cross-linking to treat eyes in which the cornea, the clear dome shaped surface that covers the front of the eye, has been weakened from the progression of the disease keratoconus or following refractive surgery, a method for correcting or improving your vision.

Tell your healthcare provider if you are pregnant or plan to become pregnant.

IMPORTANT SAFETY INFORMATION
Ulcerative keratitis, a potentially serious eye infection, can occur. Your doctor should monitor defects in the outermost corneal layer of the eye for resolution.

The most common ocular side effect is haze. Other ocular side effects include inflammation, fine white lines, dry eye, disruption of surface cells, eye pain, light sensitivity, reduced sharpness of vision, and blurred vision. The risk information provided here is not comprehensive. To learn more, talk to your healthcare provider.

Go to Prescribing Info to obtain the FDA-approved product labeling.

You are encouraged to report all side effects to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.